Patent details

EP2991666 Title: SIALYLATED GLYCOPROTEINS

Basic Information

Publication number:
EP2991666
PCT Application Number:
US2014036413
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147921167
PCT Publication Number:
WO2014179601
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SIALYLATED GLYCOPROTEINS
French Title of Invention:
GLYCOPROTÉINES SIALYLÉES
German Title of Invention:
SIALYLIERTE GLYCOPROTEINE
SPC Number:

Dates

Filing date:
01/05/2014
Grant date:
25/03/2020
EP Publication Date:
09/03/2016
PCT Publication Date:
06/11/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2020
EP B1 Publication Date:
25/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/05/2020
Expiration date:
01/05/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2020
 
 

Name:
Momenta Pharmaceuticals, Inc.
Address:
301 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
LANSING, Jonathan, C.
Address:
United States (US)

2

Name:
WASHBURN, Nathaniel
Address:
United States (US)

3

Name:
ORTIZ, Daniel
Address:
United States (US)

4

Name:
BHATNAGAR, Naveen
Address:
United States (US)

5

Name:
MECCARIELLO, Robin
Address:
United States (US)

6

Name:
SARVAIYA, Hetal
Address:
United States (US)

Priority

Priority Number:
201361818563 P
Priority Date:
02/05/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/14; C07K 16/00; C12N 9/10; C12P 21/00; C12Q 1/48;

Publication

European Patent Bulletin

Issue number:
202013
Publication date:
25/03/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages